Lorundrostat Data To Be Presented At ACC.23/WCC

mineralys therapeutics

RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced that abstracts featuring lorundrostat clinical data from both Phase 2 and Phase 1 studies have been selected for a moderated poster presentation and poster presentation at the American College of Cardiology’s 72nd Annual Scientific Session together with the World Congress of Cardiology (ACC.23/WCC), which is scheduled to take place in New Orleans, LA, on March 4-6, 2023.

Mineralys Poster Details:

Moderated Poster Title:  Highly Effective Blood Pressure Lowering with lorundrostat, a New Aldosterone Synthase Inhibitor, in Individuals with Obesity and RAAS Dysregulation
Presenter Name: David Rodman, MD, FAHA
Session Title: Treating the Whole Patient including Comorbidities
Presentation Number: 1029-05
Presentation Time and Date: 3:15 p.m. – 3:25 p.m. CT on Saturday, March 4, 2023
Session Location: Heart Failure and Cardiomyopathies Moderated Poster Theater 9, Hall F
Poster Presentation Title:  First-In-Human Study of lorundrostat, a Potent and Highly Selective Aldosterone Synthase Inhibitor
Presenter Name: David Rodman, MD, FAHA
Session Title: Heart Failure and Cardiomyopathies: Clinical Science 11
Presentation Number: 1560-160
Presentation Time: 12:45 p.m. – 1:30 p.m. CT on Sunday, March 5, 2023
Session Location: Poster Hall, Hall F

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.

Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.